Notice of Interim Results

RNS Number : 7983C

Futura Medical PLC

05 September 2008

 



For immediate release

5 September 2008

Futura Medical plc

Notification of Interim Results

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that its interim results for the  half year ended 30 June 2008 will be announced on Friday 19 September 2008.

A meeting for analysts will be held at 10am on 19 September 2008 at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE.

For further information:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.co.uk

Media enquiries: 

Buchanan Communications
Mark Court / Rebecca Skye Dietrich	Tel: [phone]

Nominated Adviser:

Canaccord Adams Limited
Ryan Gaffney / Adria Da Breo-Richards	Tel: [phone]

Notes

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.co.uk

 

END

 

 

NORSSSFMLSASELU